Showing results (441-450 of 468) with videos related to
Sort By:
Pageof 47
JAMA Network Open|July 23, 2021
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical TrialsAkash Goyal, Tony Schibler, Brooke Alhanti, et al.Journal of the American College of Cardiology|August 31, 2019
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass SurgeryShaun G Goodman, Philip E Aylward, Michael Szarek, et al.American Heart Journal|December 3, 2014
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trialGregory G Schwartz, Laurence Bessac, Lisa G Berdan, et al.European Heart Journal|November 17, 2019
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysisPeter R Sinnaeve, Gregory G Schwartz, Daniel M Wojdyla, et al.The New England Journal of Medicine|November 8, 2018
Alirocumab and Cardiovascular Outcomes after Acute Coronary SyndromeGregory G Schwartz, P Gabriel Steg, Michael Szarek, et al.Journal of the American College of Cardiology|September 17, 2013
Cardiovascular care facts: a report from the national cardiovascular data registry: 2011Frederick A Masoudi, Angelo Ponirakis, Robert W Yeh, et al.Journal of the American College of Cardiology|May 9, 2020
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES TrialDeepak L Bhatt, Andrew H Briggs, Shelby D Reed, et al.Diabetes Care|September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE TrialDennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.JAMA Cardiology|October 4, 2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical TrialAmber Sleem, Mark B Effron, Amanda Stebbins, et al.Circulation|May 24, 2019
Effect of Alirocumab on Mortality After Acute Coronary SyndromesPhilippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, et al.Pageof 47